ZUMA-5 vs SCHOLAR-5: Axicabtagene ciloleucel significantly improves FL outcome Presented ByProf. John Gribben, Barts Cancer Institute, UK TrialZUMA-5; SCHOLAR-5 ConferenceEHA 2021 5 August, 2021 11:18